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Abstract
Background: Plasma free fatty acids (FFA) are involved in blood lipid metabolism as well as many health
complications. The present study was conducted to evaluate the potential role of chlorogenic acid complex
from green coffee bean (CGA7) on FFA metabolism in high fat diet fed rats.
Methods: Hyperlipidemia was induced in Wistar rats using high-fat diet. The animals were given CGA7/orlistat
concurrently for 42 days. The parameters analysed during the study include plasma and liver total cholesterol
(TC), Triglycerides (TG) and FFA. AMPK activation in the liver was analysed through ELISA. The multiple factors
involved in AMPK mediated FFA metabolism were analysed using western blotting.
Results: CGA7 (50, 100, 150 mg/kg BW) decreased triglycerides (TG) and FFA levels in plasma and liver. CGA7
administration led to the activation of AMP-activated protein kinase (AMPK) and a subsequent increase in the
levels of carnitine palmitoyltransferase 1 (CPT-1). There was a decrease in acetyl-CoA carboxylase (ACC) activity
as evident by the increase in its phosphorylation level.
Conclusion: Chlorogenic acids improved the blood lipid metabolism in rats by alleviating the levels of FFA
and TG, modulating the multiple factors in liver through AMPK pathway. The study concludes that CGA7
complex can be promoted as an active ingredient in nutrition for obesity management.
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Background
Fatty acids in the plasma (FFA) play a crucial role in
metabolic syndrome such as obesity and type 2 diabetes
[1, 2]. Plasma FFA levels are usually elevated in obesity
due to the fact that enlarged adipose tissue mass re-
leases more FFA and its clearance reduced. Further-
more, the anti-lipolytic action of insulin is inhibited by
plasma FFA, which also increases the rate of FFA re-
lease into the circulation [2]. Glucose uptake via insulin
signalling is affected by FFA [3]. Oxidation of FFA to
form ATP, or esterification for storage as triglycerides
(TG) occurs in the liver [4]. Fatty liver is a consequence
of elevated plasma FFA resulting in intracellular accu-
mulation of lipid metabolites. Therefore, reducing the
level of plasma FFA and promoting FFA uptake and
oxidation in the liver would be a potential strategy in
the management of metabolic syndrome.
Chlorogenic acids (CGA) represent a large family of
phenolic compounds formed by the esterification of cin-
namic acids with quinic acids. Green coffee is a major
source of CGA in nature [5]. Green coffee beans have
received much attention in the west mainly due to the
beneficial effects of CGA against obesity and metabolic
disorders such as type 2 diabetes. A large body of evi-
dence suggest that CGA exhibits anti-obesity activity by
alleviating lipid metabolism in high-fat diet-fed rats [6]. Re-
cent studies showed that CGA stimulated glucose transport
via increasing expression of GLUT4 and PPAR-γ transcript.
This is due to the activation of AMP activated protein
kinase (AMPK). CGA regulates glucose and lipid metabol-
ism and improves insulin sensitivity. However, there are no
scientific reports explaining the detailed mechanism of
action of CGA complex on FFA metabolism.
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The present study investigates the hypolipidemic effects
of CGA7, a complex of seven isomers of chlorogenic acid
from green coffee beans supplied by Department of Phyto-
chemistry, Vidya Herbs Pvt Ltd., in rats.
Methods
Reagents
All the reagents and chemicals were purchased from
Sigma Aldrich Ltd. (India) unless otherwise stated. Anti-
bodies for AMP-activated protein kinase α (AMPKα) and
its phosphorylated form (pAMPKα), acetyl CoA carboxyl-
ase (ACC) and phosphor-ACC (pACC), carnitine palmi-
toyltransferase 1 (CPT-1), and β-actin were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA).
Experimental design
Forty-eight male, four week old Sprague-Dawley rats
(Biogen, Bangalore, India) were housed in stainless-
steel cages and placed in a room under a controlled
atmosphere (temperature, 22 ± 1 °C, humidity, 55 ± 5 %;
12 h light/dark cycle). During a 1-week acclimatization
period, all rats consumed a commercial diet and tap water
ad libitum. The animals were divided into six groups
(n = 6): except control animals, all other groups were
given in-house prepared high-fat-diet with or without
orlistat or CGA7 (50, 100 and 150 mg/kg b.w.) (Table 1).
CGA7 and orlistat were dissolved in water for oral admin-
istration to rats. The diets were given in the form of
pellets for six weeks. The animal studies were carried out
after the CPCSEA (Committee for the purpose of control
and supervision of experiments on animals, a statutory
committee established under the Prevention of Cruelty to
Animals Act, 1960 in India) approval through Institutional
Animal Ethical Committee (VHPL/PCL/IAEC/02/13)
independently formed by CPCSEA.
Determination of total cholesterol (TC), TG and FFA in
plasma and liver tissue
A 10 % w/v liver homogenate was prepared using 0.15 M
KCl, centrifuged at 1000 g for 10 min at 4 °C. The super-
natant was for biochemical analysis. Plasma and liver
TC and TG were measured enzymatically using com-
mercial kit (ROBONIK Prietest kit) in autoanalyzer
(Unitron Biomed). FFA was determined by GC-MS
(Schimadzu QP2010).
Determination of AMPK phosphorylation using ELISA
The activation of AMPK in liver homogenates was deter-
mined using AMPK (pT172) ELISA kit from Life technolo-
gies. The experiment was conducted as per manufacturers’
instructions. The total assay incubation time was only 4 h.
Tetramethyl benzidine (TMB) was used as substrate solu-
tion. The optical density was read on a standard microplate
reader (Multiskan EX Thermoscientific).
Western blot analysis
Proteins from the liver tissues were extracted with a
RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl,
1 % NP-40, 0.25 % deoxycholic acid, 1 mM EDTA) sup-
plemented with 1 mM phenylmethylsulfonyl fluoride. The
concentration of protein in the liver homogenates was
determined by the Bradford method. The proteins were
electrophoresed on SDS-PAGE, and transferred onto
polyvinylidene difluoride (PVDF) membranes. The mem-
branes were blocked in 2 % BSA in TBS-T (50 mmol/L
Tris HCl, pH 7.5, 150 mmol/L NaCl, 0.1 % Tween 20) for
1 h at room temperature. The membranes were kept over-
night at 4 °C with primary antibodies followed by washing
thrice with TBS-T (6 min each). The secondary antibody
incubation was for 1 h at room temperature. After apply-
ing the substrate, the blots were developed using X-ray
films. Beta actin was used as a loading control.
Statistical analysis
The data were expressed as mean ± SEM and analyzed
by one way ANOVA followed by Dunnett’s t test using
Table 1 Experimental design for the study
Groups Treatment and dose (mg/kg b.w)
I Control (Normal pellet diet)
II High fat diet
III High fat diet + Orlistat (30 mg/kg)
IV High fat diet + CGA7 (50 mg/kg)
V High fat diet + CGA7 (100 mg/kg)
VI High fat diet + CGA7 (150 mg/kg)
Table 2 Influence of CGA7 complex on weight gain and metabolic variables in HFD- fed rats
Parameter Control High fat diet High fat diet + orlistat
(30 mg/kg b.w.)
High fat diet + CGA7
(50 mg/kg b.w.)
High fat diet + CGA7
(100 mg/kg b.w.)
High fat diet + CGA7
(150 mg/kg b.w.)
Body weight gain (g) 68.41 ± 1.18 112.0 ± 4.51# # # 88.01 ± 3.68*** 75.65 ± 3.44*** 65.88 ± 2.14*** 60.63 ± 2.89***
Food intake (g/day) 14.93 ± 0.77 8.26 ± 0.51# # # 8.54 ± 0.40 7.78 ± 0.45 8.96 ± 0.45* 6.98 ± 0.35
Liver weight (g) 3.87 ± 0.18 4.50 ± 0.19# 3.47 ± 0.11*** 3.56 ± 0.10*** 3.57 ± 0.12*** 3.39 ± 0.10***
Mesenteric fat (g) 0.59 ± 0.06 1.31 ± 0.12# # # 0.98 ± 0.03* 1.01 ± 0.07* 1.0 ± 0.04* 1.00 ± 0.07*
Epididymal fat (g) 0.58 ± 0.02 2.07 ± 0.12# # # 1.26 ± 0.05* 1.06 ± 0.03*** 0.84 ± 0.02*** 0.74 ± 0.02**
Data represent the means ± SEM (n = 6). Data were analysed using one way Anova for analysing the differences between groups (#, p < 0.05, # # #, p < 0.001)
compared with control group. *, p < 0.05, **, p < 0.01 and ***, p < 0.001 compared with HFD group
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Graphpad Prism version 5. The data were considered
statistically significant at p < 0.05.
Results and discussion
CGA7 promoted weight loss and improved the lipid
profile in HFD-fed rats
The high fat diet fed rats had gained considerably more
body weight than the normal rats. CGA7 treatment how-
ever restored the body weight to normal levels in HFD
rats (Table 2). After 42 days of treatment, the HFD-fed
rats showed elevated levels of liver and plasma cholesterol,
triglycerides and free fatty acids (p < 0.001) as compared
to the normal rats (Figs. 1 & 2). There was considerable
improvement in the lipid metabolism observed in treat-
ment groups including Orlistat and CGA7 supplementation
(p < 0.001) (Figs. 1 & 3). Furthermore, CGA7 administra-
tion decreased the liver weight and epididymal fat in
HFD-fed rats (Table 2).
CGA7 modulated the regulatory enzymes of FFA
catabolism in liver of HFD rats
CGA7 complex significantly increased the phosphorylated
form of AMPK in the liver of HFD-fed rats (P < 0.01)
(Fig. 4) as evident through ELISA. It was further con-
firmed using western blotting (Fig. 5). CGA7 treatment
also influenced the expression of CPT-1 and ACC. CPT-1
plays an important role in FFA β-oxidation. ACC is a vital
enzyme required for FFA synthesis, respectively, in liver.
CGA7 increased significantly the expression of CPT-1 and
the level of ACC phosphorylation (Fig. 5). These results
indicate collectively that chlorogenic acids promote the
FFA uptake and oxidation, and inhibit FFA accumulation
by modulating the vital enzymes expression in liver of
hyperlipidemic rats.
The study investigated the effect of CGA7 on free fatty
acid metabolism in high-fat diet induced obese rats. There
are studies describing the anti-obesity mechanisms of
chlorogenic acids (CGA) [6, 7]. Rodriguez de Sotillo and
Hadley [8] reported that CGA reduced the TG and TC in
blood. However, the mechanism is not yet clear. FFA plays
an essential role in regulating triglyceride metabolism
[9]. The elevated levels of plasma FFA leads to forma-
tion of fatty liver and hyperlipidemia [10]. There are no
reports on the effect of CGA on FFA metabolism. In
the present study, CGA7 complex was shown to influ-
ence the FFA metabolism attributing to the synergistic
Fig. 1 Effect of CGA7 on plasma total cholesterol and triglyceride. Data were analyzed by one way ANOVA followed by Dunnett’s t test.
Number of animals in each group n = 6. aComparison made with control group. bComparison made with high fat diet group. ***P < 0.001,
**P < 0.01, *P < 0.05
Fig. 2 Effect of CGA 7 on liver cholesterol & triglycerides. Data were analyzed by one way ANOVA followed by Dunnett’s t test. Number
of animals in each group n = 6. aComparison made with control group. bComparison made with high fat diet group. ***P < 0.001
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effect of chlorogenic acid isomers. The presence of
seven isomers of chlorogenic acids was confirmed by
LCMS (Data not shown). Earlier reports suggest that
5-Caffeoylquinic acid (5-CQA), one of the isomers of
CGA, influence the glucose transport in skeletal muscle
through the activation of AMPK and down-regulation of
ACC [11]. 5-CQA also improves the lipid metabolism
through the regulation of AMPK [12]. Our data for the
first time demonstrated that CGA7 complex of chlorogenic
acids exert anti-hyperlipidemic effect by promoting FFA
catabolism.
There was an increase in body weight (Table 2),
plasma and liver TC, TG levels in high-fat diet fed rats
compared to rats in normal control group. Our study
for the first time showed that CGA7 complex decreased
plasma FFA levels in hyperlipidemic rats via AMPK ac-
tivation. Activated form of AMPK plays a pivotal role
in intracellular lipid metabolism [13]. In the present
study, CGA7 complex treated rats showed an upregula-
tion in the activated AMPK levels compared to high-fat
diet fed animals. Further there was an increase in CPT-
1 level and a decreased expression of pACC indicating
an inhibition of ACC activity. Inhibition of ACC activ-
ity is related to a decreased malonyl-CoA which would
otherwise inhibits the activity of CPT-1. CPT-1 plays a
crucial role in the FFA catabolism through β-oxidation
[14]. In order for lipids to be used as fuel, FFA must
be converted intracellularly into long-chain fatty-acyl-
CoAs through β-oxidation. Decreased ACC activity can
be correlated to the suppression of FFA synthesis and the
progression of FFA β-oxidation [15].
Interestingly, we found that the efficacy of CGA7 was
more pronounced at 50 mg/kg b.w. dosage group than
the higher doses of CGA7 (Fig. 5). This is in agreement
Fig. 3 Effects of CGA7 complex on plasma and liver FFA levels in hyperlipidemic rats. Data were analyzed by one way ANOVA followed by
Dunnett’s t test. Number of animals in each group n = 6. #, p < 0.05 compared with control group. *p < 0.05 compared with HFD control
Fig. 4 Regulation of AMPK by CGA7 in rat liver. Data are mean ±
SEM values of three individual experiments. The values were
compared with the control using analysis of variance followed
by unpaired student’s t tests. #p < 0.05, significant differences
from the normal control group. *p < 0.05, significant differences
from the positive control group
Fig. 5 Effects of CGA7 on the proteins expression of AMPK, CPT1
and ACC in liver of HFD fed rats
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with previous studies from Ong et al. [11] wherein ACC
phosphorylation was more prominent with the lower
concentration of CGA. The current findings clearly in-
dicate the efficacy of CGA7 on FFA catabolism via acti-
vation of AMPK.
Conclusion
The effect of isomers of chlorogenic acids in green coffee
bean on FFA metabolism and its possible mechanism has
been addressed for the first time. CGA promotes FFA
catabolism by regulating the AMPK pathway.
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